Catalyst Wire Dossier Catalyst Wire Dossier

P-PSMA-101 CAR-T cells

· Poseida Therapeutics, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for P-PSMA-101 CAR-T cells, covering 2025-02-17 to 2025-02-17. Get the full timeline:

Most recent: Clinical Trial Update: P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC) [Phase 1]

See pricing